Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002001011-25-000044
Filing Date
2025-06-10
Accepted
2025-06-10 19:24:42
Documents
1
Period of Report
2025-06-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 5839
  Complete submission text file 0002001011-25-000044.txt   7307
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Issuer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 81 WYMAN ST POST OFFICE BOX 9046 WALTHAM MA 02454
Business Address
LAMATTINA JOHN L (Reporting) CIK: 0001216074 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33093 | Film No.: 251038510